I’ve been keeping an eye on Capricor Therapeutics Inc (NASDAQ:CAPR) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe CAPR has a lot to offer. Basically, it is a financially-sound company with a a buoyant growth outlook, not yet factored into the price. Below, I’ve touched on some key aspects you should know on a high level. For those interested in digger a bit deeper into my commentary, take a look at the report on Capricor Therapeutics here.
Very undervalued with flawless balance sheet
CAPR’s share price is trading at below its true value, meaning that the market sentiment for the stock is currently bearish. Investors have the opportunity to buy into the stock to reap capital gains, if CAPR’s projected earnings trajectory does follow analyst consensus growth, which determines my intrinsic value of the company. Also, relative to the rest of its peers with similar levels of earnings, CAPR’s share price is trading below the group’s average. This bolsters the proposition that CAPR’s price is currently discounted.
CAPR’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This implies that CAPR manages its cash and cost levels well, which is a crucial insight into the health of the company. Looking at CAPR’s capital structure, the company has no debt on its balance sheet. This implies that the company is running its operations purely on off equity funding. which is typically normal for a small-cap company. Investors’ risk associated with debt is virtually non-existent and the company has plenty of headroom to grow debt in the future, should the need arise.
For Capricor Therapeutics, I’ve compiled three pertinent factors you should further research:
- Historical Performance: What has CAPR’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Dividend Income vs Capital Gains: Does CAPR return gains to shareholders through reinvesting in itself and growing earnings, or redistribute a decent portion of earnings as dividends? Our historical dividend yield visualization quickly tells you what your can expect from CAPR as an investment.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CAPR? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at email@example.com.